Literature DB >> 15861928

The argument for pharmaceutical policy.

Janine Morgall Traulsen1, Anna Birna Almarsdóttir.   

Abstract

Pharmaceutical policy is a global concern. It has become a hot political topic in most countries--developed as well as developing--and can be found on the agenda of international organizations such as WHO, OECD, EU, WTO and even the World Bank. Pharmaceutical policy affects everyone in the world of pharmacy and it is therefore imperative that it be understood, discussed and debated within the pharmacy profession and included in the curriculum of schools of pharmacy. This, the first article in a series, argues for the importance of the academic discipline of pharmaceutical policy analysis and the involvement of pharmacists in this endeavour. The aim of the authors is to stimulate an informed and critical appreciation of this field. The authors begin with an introduction to the field of pharmaceutical policy, introducing several important concepts and current trends including: medicines regulation; how pharmaceutical policy is made; pharmaceutical policy as a dynamic process; and the new public health as a global issue. The article ends with a short description of the remaining five articles in the series which will deal with important aspects of pharmaceutical policy. The topics include: economic pressures on health care systems; drug utilization from the clinical viewpoint (rational use of medicines); the impact of pharmaceutical policy on patients and the patient impact on pharmaceutical policy; the professional perspective; and finally the last article which deals with studying and evaluating pharmaceutical policy.

Entities:  

Mesh:

Year:  2005        PMID: 15861928     DOI: 10.1007/s11096-004-5151-2

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  4 in total

1.  The globalization of public health: the first 100 years of international health diplomacy.

Authors:  D P Fidler
Journal:  Bull World Health Organ       Date:  2001-10-23       Impact factor: 9.408

2.  Opportunities and responsibilities in pharmaceutical care.

Authors:  C D Hepler; L M Strand
Journal:  Am J Hosp Pharm       Date:  1990-03

3.  Drug-related morbidity and mortality. A cost-of-illness model.

Authors:  J A Johnson; J L Bootman
Journal:  Arch Intern Med       Date:  1995-10-09

4.  Towards the proletarianization of physicians.

Authors:  J B McKinlay; J Arches
Journal:  Int J Health Serv       Date:  1985       Impact factor: 1.663

  4 in total
  3 in total

1.  Studying and evaluating pharmaceutical policy--becoming a part of the policy and consultative process.

Authors:  Anna Birna Almarsdóttir; Janine M Traulsen
Journal:  Pharm World Sci       Date:  2006-06-30

2.  Policies to enhance prescribing efficiency in europe: findings and future implications.

Authors:  Brian Godman; William Shrank; Morten Andersen; Christian Berg; Iain Bishop; Thomas Burkhardt; Kristina Garuoliene; Harald Herholz; Roberta Joppi; Marija Kalaba; Ott Laius; Julie Lonsdale; Rickard E Malmström; Jaana E Martikainen; Vita Samaluk; Catherine Sermet; Ulrich Schwabe; Inês Teixeira; Lesley Tilson; F Cankat Tulunay; Vera Vlahović-Palčevski; Kamila Wendykowska; Bjorn Wettermark; Corinne Zara; Lars L Gustafsson
Journal:  Front Pharmacol       Date:  2011-01-07       Impact factor: 5.810

3.  Effects of a price cut reform on the cost and utilization of antidiabetic drugs in Korea: a national health insurance database study.

Authors:  Hae Sun Suh; Jee-Ae Kim; Iyn-Hyang Lee
Journal:  BMC Health Serv Res       Date:  2018-06-08       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.